INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

2007244 citationsJournal Article

Authors

Melvin Rabena · California Retina Consultants

Dante J. Pieramici · California Retina Consultants

Alessandro Castellarin · California Retina Consultants

Ma'an Nasir · California Retina Consultants

Robert L. Avery · California Retina Consultants

Abstract

The observed anatomic (by ophthalmic examination, OCT, and/or fluorescence angiography) and visual acuity improvements and lack of serious adverse side effects after intravitreal bevacizumab injection demonstrates, in principle, the potential of bevacizumab for the treatment of ME in this setting.

Topics & Keywords

Retinal Diseases and Treatments Vascular Malformations Diagnosis and Treatment Retinal and Macular Surgery

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Retina

Volume 27, Issue 4, pp. 419-425

DOI: 10.1097/iae.0b013e318030e77e

Field-Weighted Citation Impact: 32.48